RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Brian Abrahams maintains a Sector Perform rating on Gilead Sciences (NASDAQ:GILD) and raises the price target from $71 to $72.
August 09, 2024 | 7:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Brian Abrahams maintains a Sector Perform rating on Gilead Sciences and raises the price target from $71 to $72.
The raised price target from $71 to $72 by RBC Capital indicates a slightly more positive outlook on Gilead Sciences, which could lead to a minor positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100